Efficacy of Probiotic Therapy on Atopic Dermatitis in Adults Depends on the C-159T Polymorphism of the CD14 Receptor Gene - A Pilot Study | Zendy

Oleksandr Litus | Zendy; N. Derkach | Zendy; Віктор Літус | Zendy; Yuriy Bisyuk | Zendy; Bohdan Lytvynenko | Zendy

Open Access

Efficacy of Probiotic Therapy on Atopic Dermatitis in Adults Depends on the C-159T Polymorphism of the CD14 Receptor Gene - A Pilot Study

Author(s) -

Oleksandr Litus,

N. Derkach,

Віктор Літус,

Yuriy Bisyuk,

Bohdan Lytvynenko

Publication year - 2019

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2019.242

Subject(s) - medicine , bifidobacterium animalis , atopic dermatitis , probiotic , lactobacillus acidophilus , gastroenterology , atopy , genotype , gene polymorphism , immunology , bifidobacterium , lactobacillus , allergy , food science , biology , gene , biochemistry , genetics , fermentation , bacteria

The C-159T polymorphism of the CD14 receptor gene can be associated with the development of atopic dermatitis. Probiotics can modulate chronic inflammation through activation of the CD14 receptor. So, the efficacy of probiotic therapy can be dependent on this genetic polymorphism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research